Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...
Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...